BG
DARE icon

BlackRock Group’s Dare Bioscience DARE Stock Holding History

BlackRock Group’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-32
Closed -$8K – 2991
2016
Q2 		$8K Hold
32
– – ﹤0.01% 3003
2016
Q1 		$10K Hold
32
– – ﹤0.01% 3035
2015
Q4 		$11K Hold
32
– – ﹤0.01% 2987
2015
Q3 		$14K Hold
32
– – ﹤0.01% 3007
2015
Q2 		$18K Buy
+32
New +$22K ﹤0.01% 2909

Other funds holding DARE

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Group's DARE Position: Q3 2016 in Review

BlackRock Group sold out of Dare Bioscience (DARE) in Q3 2016, closing a stake of 32 shares — an estimated $8K sold.

BlackRock Group first reported a position in DARE in Q2 2015 and held it in 5 quarters. The position peaked at $18K in Q2 2015. 31 funds tracked by Wall St. Rank hold DARE as of Q3 2016.

  • BlackRock Group reported no remaining Dare Bioscience position as of Q3 2016 after selling out during the quarter.
  • BlackRock Group sold 32 Dare Bioscience shares in Q3 2016, an estimated $8K.
  • BlackRock Group first reported a position in Dare Bioscience in Q2 2015 and held it in 5 quarters.
  • BlackRock Group's Dare Bioscience position peaked at $18K in Q2 2015.
  • 31 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2016.

Based on BlackRock Group's 13F filing for Q3 2016, filed 8 Nov 2016.